AMSTERDAM, April 13 (Reuters) - The European medicines
watchdog on Tuesday said it was aware of a decision by its U.S.
counterpart to pause the administration of Johnson & Johnson's
COVID-19 vaccine due to rare instances of blood clots.
In a statement the European Medicines Agency (EMA) said it
is not clear there is a link between the vaccine and the
incidents and its safety committee is continuing a review
announced last week.
(Reporting by Toby Sterling, Editing by Franklin Paul)